Position in EBS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$11,206,095
+$640,951 QoQ
Shares Held
1,337,243
+5.1% QoQ
Ownership
2.61%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 194 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EBS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $4,788,152,578 across 66 Drug Manufacturers - Specialty & Generic names. EBS ranks #30 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
13,289,622 | $954,992,236 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
996,598 | $539,986,694 | |
| 3 | VTRS |
Viatris Inc
|
32,807,906 | $520,989,547 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
11,607,196 | $393,251,799 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
2,138,777 | $360,469,474 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
11,302,057 | $278,143,622 | |
| 7 | ALKS |
Alkermes plc.
|
4,477,876 | $234,640,702 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
1,841,367 | $204,281,254 |
All Filings in EBS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,206,095 | 1,337,243 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $10,565,144 | 1,272,909 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $15,450,122 | 1,250,010 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $11,278,071 | 1,278,693 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $8,160,006 | 1,278,998 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $2,975,729 | 612,290 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,648,640 | 590,862 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $4,859,348 | 581,958 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,793,160 | 556,182 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $2,836,623 | 1,121,195 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,633,325 | 1,097,219 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,464,719 | 1,019,035 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,794,957 | 924,484 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $9,287,263 | 896,454 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $10,137,869 | 858,414 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $17,556,455 | 836,420 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $25,823,759 | 831,951 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $33,572,585 | 817,647 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $36,636,429 | 842,798 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $41,211,215 | 823,072 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $53,092,822 | 842,877 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $76,551,522 | 823,932 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $61,800,166 | 689,734 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $67,170,802 | 650,061 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $51,770,908 | 654,665 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $37,105,154 | 641,292 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||